Cargando…
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
Endothelial cells express surface angiotensin-converting enzyme 2 (ACE2), the main receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that promotes the infection of endothelial cells showing activation and damage. Bronchoalveolar lavage fluid from coronavirus disease-2019 (COV...
Autores principales: | Nagy, Béla, Fejes, Zsolt, Szentkereszty, Zoltán, Sütő, Renáta, Várkonyi, István, Ajzner, Éva, Kappelmayer, János, Papp, Zoltán, Tóth, Attila, Fagyas, Miklós |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689308/ https://www.ncbi.nlm.nih.gov/pubmed/33249290 http://dx.doi.org/10.1016/j.ijid.2020.11.184 |
Ejemplares similares
-
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients
por: Fagyas, Miklós, et al.
Publicado: (2022) -
Profiling of Lactate Dehydrogenase Isoenzymes in COVID-19 Disease
por: Dzsudzsák, Erika, et al.
Publicado: (2021) -
Circulating ACE2 activity correlates with cardiovascular disease development
por: Úri, Katalin, et al.
Publicado: (2016) -
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
por: Fagyas, Miklós, et al.
Publicado: (2014) -
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases
por: Fagyas, Miklós, et al.
Publicado: (2014)